Clinical Trials Logo

Clinical Trial Summary

Dysglycemia is an important pre-risk condition which can potentially lead to diabetes if not adequately treated. The variation of glycemic balance can lead to cardiovascular disorders. The study will evaluate if Reglicem®, a nutraceutical containing Berberine, Curcumin, Inositol, Banaba, and Chromium Picolinate, can ameliorate glycemic status in patients with dysglycemia.


Clinical Trial Description

Dysglycemia is an important pre-risk condition which can potentially lead to diabetes if not adequately treated. The variation of glycemic balance can lead to cardiovascular disorders. The study will evaluate if Reglicem®, a nutraceutical containing Berberine, Curcumin, Inositol, Banaba, and Chromium Picolinate, can ameliorate glycemic status in patients with dysglycemia.

The investigators will enroll patients with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), not taking other hypoglycemic compounds. Patients will be randomized to take Reglicem® or placebo for 3 months, in a randomized, double-blind, placebo-controlled design. Reglicem® and placebo will be self-administered once a day, 1 tablet during the breakfast. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04107987
Study type Interventional
Source University of Pavia
Contact
Status Completed
Phase Phase 3
Start date October 1, 2018
Completion date August 31, 2019

See also
  Status Clinical Trial Phase
Terminated NCT03670017 - Glucose Time-In-Range Development Evaluation N/A
Recruiting NCT03306810 - Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service N/A
Recruiting NCT06019910 - Snus and Home Blood Pressure N/A
Active, not recruiting NCT01605422 - Meta-analyses of the Effect of Dietary Pulses on Acute Postprandial Metabolic Control N/A
Completed NCT04107922 - Nutraceutical on Hyperglycemia Phase 3
Recruiting NCT06348550 - Effect of the Association of Berberine Fitosoma® and Monacolin K MonaKoPure® on Glyco-metabolic Parameters in Dysglycemic and Dyslipidemic Patients. N/A
Recruiting NCT06050265 - Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome N/A
Not yet recruiting NCT02960373 - Dried Fruit and Postprandial Glycemia Trial N/A
Completed NCT03299205 - Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions N/A
Active, not recruiting NCT05191160 - The Soy Treatment Evaluation for Metabolic Health (STEM) Trial N/A
Recruiting NCT05852054 - Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP) Phase 3
Active, not recruiting NCT04767672 - Study to Assess the Effects of Non Digestible Carbohydrates on Long-Term Glucose Homeostasis in Untreated Prediabetic Subjects N/A
Completed NCT03543644 - Strategies To OPpose Sugars With Non-nutritive Sweeteners Or Water (STOP Sugars NOW) Trial N/A
Recruiting NCT05277558 - Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Completed NCT04525508 - Coronary Artery Plaque Burden in Asymptomatic Danish Men Aged 65-75 Years and the Relation to Glycemic Status.
Active, not recruiting NCT02037321 - Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk N/A
Active, not recruiting NCT01608620 - Meta-analyses of Fructose-containing Sugars and Incident Cardiometabolic Disease N/A
Active, not recruiting NCT01608607 - Meta-analysis of Fructose-Containing Sugar Sweetened Beverages (SSBs) and Weight Change N/A
Completed NCT01630980 - Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome N/A
Active, not recruiting NCT01363791 - Meta-analyses of Fructose and Cardiometabolic Risk N/A